Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christiaan Bartlett

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|July 4, 2009
Laboratory issues in the implementation of the marker methodDavid A Cowan, Christiaan Bartlett
Journal of Analytical Toxicology|October 17, 2016
Increases in Serum Growth Hormone Concentrations Associated with GHB AdministrationAlan D Brailsford, Christiaan Bartlett, Andrew T Kicman, et al.
Journal of Analytical Toxicology|December 2, 2006
Detection of the administration of human erythropoietin (HuEPO) to caninesChristiaan Bartlett, Gerard J Clancy, David A Cowan, et al.
Drug Testing and Analysis|February 19, 2016
Novel markers to detect recombinant human insulin-like growth factor-I (rhIGF-I)/rhIGF binding protein-3 (rhIGFBP-3) misuse in athletesRichard I G Holt, Nishan Guha, Walailuck Böhning, et al.
Clinical Diabetes and Endocrinology|February 16, 2018
Why do endocrine profiles in elite athletes differ between sports?Peter H Sönksen, Richard I G Holt, Walailuck Böhning, et al.
BMC Research Notes|September 7, 2018
A correction to the age-adjustment of the GH-2000 score used in the detection of growth hormone misuseDankmar Böhning, Walailuck Böhning, Nishan Guha, et al.
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|May 27, 2009
Moving one step closer to catching the GH cheats: The GH-2004 experienceRichard I G Holt, E Eryl Bassett, Ioulietta Erotokritou-Mulligan, et al.
Clinical Endocrinology|July 12, 2008
Influence of ethnicity on IGF-I and procollagen III peptide (P-III-P) in elite athletes and its effect on the ability to detect GH abuseIoulietta Erotokritou-Mulligan, E Eryl Bassett, David A Cowan, et al.
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|February 7, 2012
The development of decision limits for the implementation of the GH-2000 detection methodology using current commercial insulin-like growth factor-I and amino-terminal pro-peptide of type III collagen assaysIoulietta Erotokritou-Mulligan, Nishan Guha, Michael Stow, et al.
Drug Testing and Analysis|April 19, 2012
The effects of a freeze-thaw cycle and pre-analytical storage temperature on the stability of insulin-like growth factor-I and pro-collagen type III N-terminal propeptide concentrations: Implications for the detection of growth hormone misuse in athletesNishan Guha, Ioulietta Erotokritou-Mulligan, Christiaan Bartlett, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|July 4, 2009
Laboratory issues in the implementation of the marker methodDavid A Cowan, Christiaan Bartlett
Journal of Analytical Toxicology|October 17, 2016
Increases in Serum Growth Hormone Concentrations Associated with GHB AdministrationAlan D Brailsford, Christiaan Bartlett, Andrew T Kicman, et al.
Journal of Analytical Toxicology|December 2, 2006
Detection of the administration of human erythropoietin (HuEPO) to caninesChristiaan Bartlett, Gerard J Clancy, David A Cowan, et al.
Drug Testing and Analysis|February 19, 2016
Novel markers to detect recombinant human insulin-like growth factor-I (rhIGF-I)/rhIGF binding protein-3 (rhIGFBP-3) misuse in athletesRichard I G Holt, Nishan Guha, Walailuck Böhning, et al.
Clinical Diabetes and Endocrinology|February 16, 2018
Why do endocrine profiles in elite athletes differ between sports?Peter H Sönksen, Richard I G Holt, Walailuck Böhning, et al.
BMC Research Notes|September 7, 2018
A correction to the age-adjustment of the GH-2000 score used in the detection of growth hormone misuseDankmar Böhning, Walailuck Böhning, Nishan Guha, et al.
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|May 27, 2009
Moving one step closer to catching the GH cheats: The GH-2004 experienceRichard I G Holt, E Eryl Bassett, Ioulietta Erotokritou-Mulligan, et al.
Clinical Endocrinology|July 12, 2008
Influence of ethnicity on IGF-I and procollagen III peptide (P-III-P) in elite athletes and its effect on the ability to detect GH abuseIoulietta Erotokritou-Mulligan, E Eryl Bassett, David A Cowan, et al.
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|February 7, 2012
The development of decision limits for the implementation of the GH-2000 detection methodology using current commercial insulin-like growth factor-I and amino-terminal pro-peptide of type III collagen assaysIoulietta Erotokritou-Mulligan, Nishan Guha, Michael Stow, et al.
Drug Testing and Analysis|April 19, 2012
The effects of a freeze-thaw cycle and pre-analytical storage temperature on the stability of insulin-like growth factor-I and pro-collagen type III N-terminal propeptide concentrations: Implications for the detection of growth hormone misuse in athletesNishan Guha, Ioulietta Erotokritou-Mulligan, Christiaan Bartlett, et al.
Pageof 2